PUBLISHED FOR OPPOSITION
on 29 Oct 2024
Last Applicant/ Owned by
3115 Merryfield Row, Suite 200
San Diego
CA
92121
Serial Number
98313180 filed on 13th Dec 2023
Registration Number
N/A
Correspondent Address
Rosaleen H. Chou
Rosaleen H. Chou Knobbe, Martens, Olson & Bear, LLP
Knobbe, Martens, Olson & Bear, LLP
Irvine, CA 92614
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SNAPAAV
Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical, and medical research services in the field of biological treatment and bioproduction; design and development of biotechnology platforms relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; providing scientific research information, namely, provision of information for research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services, namely, the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing for others, namely, platforms for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98313180
Mark Type
No Service Mark
Attorney Docket Number
No NATIR.062T
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Oct 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 29th Oct 2024 | PUBLISHED FOR OPPOSITION |
| 09th Oct 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 19th Sep 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 30th Aug 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 30th Aug 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Aug 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 16th Jul 2024 | NON-FINAL ACTION E-MAILED |
| 16th Jul 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 16th Jul 2024 | NON-FINAL ACTION WRITTEN |